Clinical trial
Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program
NCT00401726
Study timeline
Study start (unknown)2006-06-01Date precision: month
Registry last updated2012-04-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Depressive Disorder, Majorunresolved
Interventions
Venlafaxine ERDRUG
Dialogues Time to Talk ProgramBEHAVIORAL
Sponsors & collaborators
Wyeth is now a wholly owned subsidiary of Pfizerlead sponsor
Mapped research locations
BirminghamAlabama, United States2CharlotteNorth Carolina, United States2DallasTexas, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1CincinnatiOhio, United States1ColumbusOhio, United States1OmahaNebraska, United States1Salt Lake CityUtah, United States1Las VegasNevada, United States1Little RockArkansas, United States1Fort WorthTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00401726 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.